Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001493152-24-050846
Filing Date
2024-12-20
Accepted
2024-12-20 06:12:35
Documents
9

Document Format Files

Seq Description Document Type Size
1 forms-1.htm S-1 652437
2 ex5-1.htm EX-5.1 28394
3 ex23-1.htm EX-23.1 4265
4 ex107.htm EX-FILING FEES 14104
5 ex5-1_001.jpg GRAPHIC 11480
6 ex5-1_002.jpg GRAPHIC 1474
7 forms-1_001.jpg GRAPHIC 6238
8 ex23-1_001.jpg GRAPHIC 23077
9 ex23-1_002.jpg GRAPHIC 93973
  Complete submission text file 0001493152-24-050846.txt   888758
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-283949 | Film No.: 241564989
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)